Patents by Inventor Yuko Shingu

Yuko Shingu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10870669
    Abstract: The present invention provides a novel glyceroglycolipid produced by Mycoplasma pneumoniae. The glyceroglycolipid can be used as a diagnostic marker for a disease caused by Mycoplasma pneumoniae.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: December 22, 2020
    Assignee: M BIO TECHNOLOGY INC.
    Inventors: Kazuhiro Matsuda, Yuko Shingu
  • Publication number: 20190161512
    Abstract: The present invention provides a novel glyceroglycolipid produced by Mycoplasma pneumoniae. The glyceroglycolipid can be used as a diagnostic marker for a disease caused by Mycoplasma pneumoniae.
    Type: Application
    Filed: December 27, 2018
    Publication date: May 30, 2019
    Applicant: M BIO TECHNOLOGY INC.
    Inventors: Kazuhiro MATSUDA, Yuko SHINGU
  • Patent number: 8367076
    Abstract: The present invention provides a novel glyceroglycolipid produced by Mycoplasma pneumoniae. The glyceroglycolipid can be used as a diagnostic marker for a disease caused by Mycoplasma pneumoniae.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: February 5, 2013
    Assignee: M Bio Technology Inc.
    Inventors: Kazuhiro Matsuda, Yuko Shingu
  • Publication number: 20090263823
    Abstract: The present invention provides a novel glyceroglycolipid produced by Mycoplasma pneumoniae. The glyceroglycolipid can be used as a diagnostic marker for a disease caused by Mycoplasma pneumoniae.
    Type: Application
    Filed: June 13, 2007
    Publication date: October 22, 2009
    Inventors: Kazuhiro Matsuda, Yuko Shingu